• Measure Summary
  • NQMC:010790
  • 2016 Jul
  • NQF-Endorsed Measure

Hospital-based inpatient psychiatric services: the total number of hours that all patients admitted to a hospital-based inpatient psychiatric setting were maintained in physical restraint.

The Joint Commission

  • Measure Summary
  • NQMC:010141
  • 2015 Oct
  • NQF-Endorsed Measure

Tobacco treatment: percent of patients who received counseling AND medication as well as those who received counseling and had reason for not receiving the medication during the hospital stay within the first three days after admission.

The Joint Commission

  • Measure Summary
  • NQMC:010147
  • 2015 Oct
  • NQF-Endorsed Measure

Substance use: percent of patients who screened positive for unhealthy alcohol use who received the brief intervention during the hospital stay.

The Joint Commission

  • Measure Summary
  • NQMC:010125
  • 2015 Oct

Venous thromboembolism (VTE): percent of patients diagnosed with confirmed VTE that are discharged to home, home care, court/law enforcement or home on hospice care on warfarin with written discharge instructions that address all four criteria: compliance issues, dietary advice, follow-up monitoring, and information about the potential for adverse drug reactions/interactions.

The Joint Commission

  • Measure Summary
  • NQMC:010127
  • 2015 Oct
  • NQF-Endorsed Measure

Stroke: percent of ischemic and hemorrhagic stroke patients who received VTE prophylaxis or who have documentation why no VTE prophylaxis was given the day of or the day after hospital admission.

The Joint Commission

  • Measure Summary
  • NQMC:010133
  • 2015 Oct

Stroke: percent of ischemic or hemorrhagic stroke patients or their caregivers who were given educational materials during the hospital stay addressing all five specified education categories.

The Joint Commission

  • Measure Summary
  • NQMC:010130
  • 2015 Oct
  • NQF-Endorsed Measure

Stroke: percent of acute ischemic stroke patients for whom IV t-PA was initiated at the hospital within 3 hours (less than or equal to 180 minutes) of time last known well.

The Joint Commission

  • Measure Summary
  • NQMC:010139
  • 2015 Oct
  • NQF-Endorsed Measure

Tobacco treatment: percent of hospitalized patients who are screened within the first three days of admission for tobacco use (cigarettes, smokeless tobacco, pipe and cigars) within the past 30 days.

The Joint Commission

  • Measure Summary
  • NQMC:010142
  • 2015 Oct
  • NQF-Endorsed Measure

Tobacco treatment: percent of patients identified as tobacco product users within the past 30 days who were referred to or refused evidence-based outpatient counseling AND received or refused a prescription for FDA-approved cessation medication upon discharge.

The Joint Commission

  • Measure Summary
  • NQMC:010126
  • 2015 Oct

Venous thromboembolism (VTE): percent of patients diagnosed with confirmed VTE during hospitalization (not present at admission) who did not receive VTE prophylaxis between hospital admission and the day before the VTE diagnosis testing order date.

The Joint Commission

  • Measure Summary
  • NQMC:010145
  • 2015 Oct
  • NQF-Endorsed Measure

Substance use: percent of hospitalized patients who are screened within the first three days of admission using a validated screening questionnaire for unhealthy alcohol use.

The Joint Commission

  • Measure Summary
  • NQMC:010128
  • 2015 Oct
  • NQF-Endorsed Measure

Stroke: percent of ischemic stroke patients prescribed antithrombotic therapy at hospital discharge.

The Joint Commission

  • Measure Summary
  • NQMC:010791
  • 2016 Jul
  • NQF-Endorsed Measure

Hospital-based inpatient psychiatric services: the total number of hours that all patients admitted to a hospital-based inpatient psychiatric setting were held in seclusion.

The Joint Commission

  • Measure Summary
  • NQMC:010148
  • 2015 Oct
  • NQF-Endorsed Measure

Substance use: percent of patients who are identified with alcohol or drug use disorder who received or refused at discharge a prescription for FDA-approved medication for alcohol or drug disorder or who received or refused a referral for addictions treatment.

The Joint Commission

  • Measure Summary
  • NQMC:010131
  • 2015 Oct
  • NQF-Endorsed Measure

Stroke: percent of ischemic stroke patients administered antithrombotic therapy by the end of hospital day 2.

The Joint Commission

  • Measure Summary
  • NQMC:010134
  • 2015 Oct
  • NQF-Endorsed Measure

Stroke: percent of ischemic or hemorrhagic stroke patients who were assessed for rehabilitation services.

The Joint Commission

  • Measure Summary
  • NQMC:010143
  • 2015 Oct
  • NQF-Endorsed Measure

Tobacco treatment: percent of patients who were referred to evidence-based outpatient counseling AND received a prescription for FDA-approved cessation medication upon discharge as well as those who were referred to outpatient counseling and had reason for not receiving a prescription for medication.

The Joint Commission

  • Measure Summary
  • NQMC:010789
  • 2016 Jul
  • NQF-Endorsed Measure

Hospital-based inpatient psychiatric services: the percentage of patients admitted to a hospital-based inpatient psychiatric setting who are screened within the first three days of admission for all of the following: risk of violence to self or others, substance use, psychological trauma history and patient strengths.

The Joint Commission

  • Measure Summary
  • NQMC:010140
  • 2015 Oct
  • NQF-Endorsed Measure

Tobacco treatment: percent of patients identified as tobacco product users within the past 30 days who receive or refuse practical counseling to quit AND receive or refuse FDA-approved cessation medications during the hospital stay within the first three days after admission.

The Joint Commission

  • Measure Summary
  • NQMC:010129
  • 2015 Oct
  • NQF-Endorsed Measure

Stroke: percent of ischemic stroke patients with atrial fibrillation/flutter who are prescribed anticoagulation therapy at hospital discharge.

The Joint Commission